One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Flashback Foreword: Erlotinib and Gemcitabine in Pancreatic Cancer.
Ko, Andrew H. MD, FASCO 1,2,,
doi : 10.1200/JCO.23.00222
Volume 41(30) pgs. 4711-4826 October 20, 2023
JCO Flashback: A Comparison of Erlotinib Plus Gemcitabine vs Gemcitabine Alone in Treating Advanced Pancreatic Cancer (2007).
doi : 10.1200/JCO.23.00969
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group.
Moore, Malcolm J.; Goldstein, David; Hamm, John; Figer, Arie; Hecht, Joel R.; Gallinger, Steven; Au, Heather J.; Murawa, Pawel; Walde, David; Wolff, Robert A.; Campos, Daniel; Lim, Robert; Ding, Keyue; Clark, Gary; Voskoglou-Nomikos, Theodora; Ptasynski, Mieke; Parulekar, Wendy
doi : 10.1200/JCO.22.02770
You Get (offered) What You (can) Pay for: Explaining Disparities in End-of-Life Cancer Care.
Prigerson, Holly G. PhD 1,; Neugut, Alfred I. MD, PhD 2,
doi : 10.1200/JCO.23.00608
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
Cash, Thomas MD, MSc 1,,; Krailo, Mark D. PhD 2,3,; Buxton, Allen B. MS 2; Pawel, Bruce R. MD 4; Healey, John H. MD 5,; Binitie, Odion MD 6,; Marcus, Karen J. MD 7,; Grier, Holcombe E. MD 8; Grohar, Patrick J. MD, PhD 9,; Reed, Damon R. MD 10,; Weiss, Aaron R. DO 11,; Gorlick, Richard MD 12,; Janeway, Katherine A. MD, MMSC 8,; DuBois, Steven G. MD, MS 8,; Womer, Richard B. MD 9
doi : 10.1200/JCO.23.00053
End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting.
Canavan, Maureen MPH, PhD 1; Wang, Xiaoliang PhD 2,; Ascha, Mustafa PhD 2,; Miksad, Rebecca MD 2,3,; Showalter, Timothy N. MD 2,; Calip, Gregory PhD 2,4,; Gross, Cary P. MD 1,; Adelson, Kerin MD 1,5,,
doi : 10.1200/JCO.22.02180
Discussions About Goals of Care and Advance Care Planning Among Adolescents and Young Adults With Cancer Approaching the End of Life.
Mack, Jennifer W. MD, MPH 1,2,; Cernik, Colin MS 1,; Uno, Hajime PhD 1; Xu, Lanfang MS 3; Laurent, Cecile A. MS 4; Fisher, Lauren MS 1; Cannizzaro, Nancy BA 5; Munneke, Julie BA 4; Cooper, Robert M. MD 6; Lakin, Joshua R. MD 7; Schwartz, Corey M. MD 8,; Casperson, Mallory MS 9,; Altschuler, Andrea PhD 4; Wiener, Lori PhD 10; Kushi, Lawrence ScD 4; Chao, Chun R. PhD 5,
doi : 10.1200/JCO.23.00641
High-Temporal/High-Spatial Resolution Breast Magnetic Resonance Imaging Improves Diagnostic Accuracy Compared With Standard Breast Magnetic Resonance Imaging in Patients With High Background Parenchymal Enhancement.
Eskreis-Winkler, Sarah MD, PhD 1,; Sung, Janice S. MD 1,; Dixon, Linden MD 1; Monga, Natasha MD 1; Jindal, Ragni MD 1; Simmons, Amber BS 2; Thakur, Sunitha PhD 1; Sevilimedu, Varadan MBBS, DrPH 3; Sutton, Elizabeth MD 1; Comstock, Christopher MD 1,; Feigin, Kimberly MD 1,; Pinker, Katja MD, PhD 1,
doi : 10.1200/JCO.22.00635
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.
Diab, Adi MD 1,,; Gogas, Helen MD, PhD 2,; Sandhu, Shahneen MBBS, FRACP 3,; Long, Georgina V. BSc, PhD, MBBS, FRACP 4,; Ascierto, Paolo A. MD 5,; Larkin, James MD, PhD, FRCP 6,; Sznol, Mario MD 7,; Franke, Fabio MD 8; Ciuleanu, Tudor E. MD 9,; Pereira, Caio MD 10,; Munoz Couselo, Eva MD 11,; Bronzon Damian, Fernanda MD 12; Schenker, Michael MD, PhD 13,; Perfetti, Aldo MD 14; Lebbe, Celeste MD, PhD 15,; Quereux, Gaelle MD 16,; Meier, Friedegund MD 17,18,; Curti, Brendan D. MD 19,; Rojas, Carlos MD 20,; Arriaga, Yull MD 21,; Yang, Haisu PhD 21; Zhou, Ming PhD 21,; Ravimohan, Shruthi PhD 22,; Statkevich, Paul PhD 23,; Tagliaferri, Mary A. MD 24,; Khushalani, Nikhil I. MD 25,
doi : 10.1200/JCO.23.00172
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
Kurtz, Jean-Emmanuel MD, PhD 1,,; Pujade-Lauraine, Eric MD 2,; Oaknin, Ana MD 3,; Belin, Lisa MSc 4; Leitner, Katharina MD 5,; Cibula, David MD 6,; Denys, Hannelore MD 7,; Rosengarten, Ora MD 8; Rodrigues, Manuel MD 9,; de Gregorio, Nikolaus MD 10,11,; Martinez Garcia, Jeronimo MD 12; Petru, Edgar MD 13,; Kocian, Roman MD 6; Vergote, Ignace MD 14,; Pautier, Patricia MD 15,; Schmalfeldt, Barbara MD 16,; Gaba, Lydia MD 17,; Polterauer, Stephan MD 18,; Mouret Reynier, Marie-Ange MD 19; Sehouli, Jalid MD 20,21,; Churruca, Cristina MD 22
doi : 10.1200/JCO.23.00529
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study.
Colombo, Nicoletta MD 1,2,,; Van Gorp, Toon MD, PhD 3,; Matulonis, Ursula A. MD 4,; Oaknin, Ana MD, PhD 5,; Grisham, Rachel N. MD 6,; Fleming, Gini F. MD 7,; Olawaiye, Alexander B. MD 8,; Nguyen, Dorothy D. MD 9,; Greenstein, Andrew E. PhD 9,; Custodio, Joseph M. PhD 9,; Pashova, Hristina I. PhD 9,; Tudor, Iulia C. PhD 9,; Lorusso, Domenica MD, PhD 10,
doi : 10.1200/JCO.22.02624
Inhibiting the Glucocorticoid Receptor to Enhance Chemotherapy Response.
Prekovic, Stefan PhD 1; Zwart, Wilbert PhD 2,,
doi : 10.1200/JCO.23.01195
Systemic Therapy for Melanoma: ASCO Guideline Update.
Seth, Rahul DO 1; Agarwala, Sanjiv S. MD 2; Messersmith, Hans MPH 3; Alluri, Krishna C. MD 4,; Ascierto, Paolo A. MD 5,; Atkins, Michael B. MD 6,; Bollin, Kathryn MD 7,; Chacon, Matias MD 8,; Davis, Nancy MD 9,; Faries, Mark B. MD 10,; Funchain, Pauline MD 11,; Gold, Jason S. MD 12,; Guild, Samantha JD 13; Gyorki, David E. MBBS 14,; Kaur, Varinder MD 15,; Khushalani, Nikhil I. MD 16,; Kirkwood, John M. MD 17,; McQuade, Jennifer Leigh MD 18,; Meyers, Michael O. MD 19; Provenzano, Anthony MD 20,; Robert, Caroline MD, PhD 21,; Santinami, Mario MD 22; Sehdev, Amikar MPH, MD 23,; Sondak, Vernon K. MD 16,; Spurrier, Gilliosa MSc 24,; Swami, Umang MS, MD 25,; Truong, Thach-Giao MD 26,; Tsai, Katy K. MD 27,; van Akkooi, Alexander MD, PhD 28,; Weber, Jeffrey MD, PhD 29,
doi : 10.1200/JCO.23.01136
Surprisingly High Rate of Incomplete Resection in the Control Arm.
Cohen, Romain MD, PhD; Andre, Thierry MD; Lefevre, Jeremie H. MD, PhD
doi : 10.1200/JCO.23.00250
FOxTROT Study Results: Some Burning Questions Need Answers.
Chakrabarti, Sakti MD; Mahipal, Amit MBBS
doi : 10.1200/JCO.23.00359
Reply to S. Chakrabarti et al, R. Cohen et al, and D.C. Guven.
Gray, Richard MSc; Seymour, Matt MD; Magill, Laura PhD; Handley, Kelly PhD; Quirke, Philip MD; West, Nick MD; Morton, Dion MD
doi : 10.1200/JCO.23.00694
Erratum: Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer.
doi : 10.1200/JCO.23.01807
Erratum: Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol.
doi : 10.1200/JCO.23.01844
Erratum: FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
doi : 10.1200/JCO.23.01858
Erratum: Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation.
doi : 10.1200/JCO.23.01860
